232 Treatment of Chronic Lung Disease Associated Pulmonary Hypertension with Inhaled Nitric Oxide Administered via Nasal Cpap

被引：0

作者：

F Sandri

G Ancora

G Bronzetti

M G Capretti

R Sciutti

C Massardo

机构：

[1] Neonatology,

[2] Pediatrics,undefined

[3] Pediatric Cardiology,undefined

[4] Cardiology,undefined

[5] Pediatric Radiology,undefined

[6] Radiology,undefined

[7] INO Therapeutics,undefined

[8] INO Therapeutics,undefined

来源：

Pediatric Research | 2004年 / 56卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: Pulmonary hypertension (PH) is a major complication of chronic lung disease (CLD), and its treatment is based on the use of oxygen. Inhaled nitric oxide (iNO) is a highly selective pulmonary vasodilator and it has been used in the therapy of this condition via endotrachal tube during mechanical ventilation. Its use in CLD associated PH with non-invasive delivering methods has not yet been documented to our knowledge.

引用

页码：503 / 503